Literature DB >> 2387991

Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis.

R Yanagihara1, C L Jenkins, S S Alexander, C A Mora, R M Garruto.   

Abstract

A serologic survey for human T lymphotropic virus type I (HTLV-I) infection was conducted on nearly half of the entire 260-member Hagahai population, a hunter-horticulturist group occupying the northern banks of the Yuat River Gorge in Madang Province of Papua New Guinea. For comparison, sera from two neighboring groups, the Pinai and Haruai, were tested. As determined by enzyme-linked immunosorbent assay (ELISA) and verified by Western immunoblot, IgG antibodies against HTLV-I were detected in 17 of 120 Hagahai, giving an HTLV-I seroprevalence of 14%, which is as high as that found in HTLV-I-endemic regions such as southwestern Japan and the Caribbean basin. Infection tended to cluster in family groups and was more common with increasing age. The majority of ELISA-positive (45/61) Hagahai sera were indeterminate, with 62% (28/45) exhibiting reactivity to three or more gag-encoded proteins. The clinical significance of the high frequency of indeterminate HTLV-I Western immunoblots is unknown, but it is not unlike that encountered in other Melanesian populations. Whether this reflects incomplete specific reactivity to HTLV-I or the existence of HTLV-I-related retroviruses in Papua New Guinea is being investigated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387991     DOI: 10.1093/infdis/162.3.649

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.

Authors:  N T Constantine; M Fathi Sheba; A L Corwin; R S Danahy; J D Callahan; D M Watts
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

2.  HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia.

Authors:  M Yamashita; A Achiron; T Miura; J Takehisa; E Ido; T Igarashi; K Ibuki; M Osame; S Sonoda; E Melamed
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea.

Authors:  R C Sanders; P M Wai'in; S S Alexander; A G Levin; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

5.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.

Authors:  A Gessian; R Yanagihara; G Franchini; R M Garruto; C L Jenkins; A B Ajdukiewicz; R C Gallo; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

7.  Genetic and phylogenetic analyses of human T-cell lymphotropic virus type I variants from Melanesians with and without spastic myelopathy.

Authors:  V R Nerurkar; K J Song; R R Melland; R Yanagihara
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

8.  Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto.

Authors:  J Chiavetta; J Nusbacher; F Tam; A Wall; J Steaffens; H Lee
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

9.  Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea.

Authors:  R Yanagihara; V R Nerurkar; R M Garruto; M A Miller; M E Leon-Monzon; C L Jenkins; R C Sanders; P P Liberski; M P Alpers; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya, Indonesia.

Authors:  K R Porter; L Liang; G W Long; M J Bangs; R Anthony; E M Andersen; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.